Antares Pharma announced positive results from a human factors usability study for VIBEX Methotrexate, a proprietary auto injector product designed to self-administer a rapid subcutaneous weekly ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the first shipment of commercial-ready VIBEXâ„¢ auto-injector devices to Teva at the end of the first quarter 2013. This ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex:AIS), a leader in self-injection drug delivery technology, today announced the latest advancement in its proprietary line of VIBEXâ„¢ ...
Antares Pharma, Inc. has reported positive results from a multi-centre phase II clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...
GotoX's artificial intelligence (AI)-powered platform, VibeX, which offers a "vibecoding" service, is expanding its overseas user base, beginning with the South American market. At the same time, ...
Antares Pharma, Inc. has announced positive results from a multi-center phase 2 clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...
Antares Pharma, Inc. announced that the first patient has been dosed in a clinical study evaluating the Vibex MTX product which is being developed for the treatment of rheumatoid arthritis. The ...
Avedro announced that it has submitted a New Drug Application (NDA) to the FDA for VibeX (riboflavin ophthalmic solution)/KXL System for the treatment of keratoconus and corneal ectasia following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results